These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Lipoproteins versus structural glycoproteins: atherosclerosis as an analogue and competitor of normal connective tissue interactions. Bowness JM Med Hypotheses; 1976; 2(5):200-2. PubMed ID: 184370 [TBL] [Abstract][Full Text] [Related]
24. Biological autoxidation. II. Cholesterol esters as inert barrier antioxidants. Self-assembly of porous membrane sacs. An hypothesis. Kon SH Med Hypotheses; 1978; 4(6):559-80. PubMed ID: 748727 [TBL] [Abstract][Full Text] [Related]
25. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis. de Graaf J; Hendriks JC; Swinkels DW; Demacker PN; Stalenhoef AF Artery; 1993; 20(4):201-30. PubMed ID: 8250739 [TBL] [Abstract][Full Text] [Related]
26. [The role of modified oxidation of low density lipoprotein in pathognesis of atherosclerosis]. Siennicka A; Zapolska-Downar D Postepy Hig Med Dosw; 2003; 57(2):219-37. PubMed ID: 12866357 [TBL] [Abstract][Full Text] [Related]
27. [Low density lipoprotein (LDL) heterogeneity and atherosclerosis]. Dejager S; Cohen R; Bruckert E Ann Biol Clin (Paris); 1990; 48(3):154-60. PubMed ID: 2191608 [TBL] [Abstract][Full Text] [Related]
29. [Serum lipoprotein and atherogenicity--relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation and glycation]. Takeuchi N; Saheki S Rinsho Byori; 1995 Aug; 43(8):753-62. PubMed ID: 7474432 [TBL] [Abstract][Full Text] [Related]
30. The low density lipoprotein and low density lipoprotein receptors and their possible importance in the pathogenesis of atherosclerosis. Dresel HA; Friedrich EA; Otto I; Waldherr R; Schettler G Arzneimittelforschung; 1985; 35(12A):1936-40. PubMed ID: 3913426 [TBL] [Abstract][Full Text] [Related]